Back to search

Article

A 12-month randomised, double-blind, controlled, multicentre trial comparing changes in Cigarette consumption after switchinG to high or low nicotine strENght E-cigaretteS In smokers with Schizophrenia spectrum disorders: Protocol for the GENESIS Trial

2020-10-20

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Smoking prevalence among people with mental disorders is about two to four times higher than in the general population. As a result of high smoking rates, people with a mental health condition also have high rates of morbidity and mortality from smoking-related diseases compared with the general population. Progress in reducing smoking prevalence in people with mental health d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b359edc-1506-512d-a4a1-0db64db28680
DOI
10.1101/2020.10.15.20141457
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A 12-month randomised, double-blind, controlled, multicentre trial comparing changes in Cigarette consumption after switchinG to high or low nicotine strENght E-cigaretteS In smokers with Schizophrenia spectrum disorders: Protocol for the GENESIS TrialDOI 10.1101/2020.10.15.20141457
Safety and tolerability of electronic cigarettes to reduce cigarette smoking: Secondary analysis from a randomized placebo-controlled trialSemantic proximity
Changes in Cardiovascular Disease Risk, Lung Function, and Other Clinical Health Outcomes When People Who Smoke Use E-cigarettes to Reduce Cigarette Smoking: An Exploratory Analysis from a Randomized Placebo-Controlled TrialSemantic proximity
Results of an observational intervention trial: A promising harm reduction approach for persons with mental health and substance use disordersSemantic proximity
Tobacco Use Disorder.Semantic proximity
HARMONY (HARM reduction for Opiates, Nicotine and You): Statistical Analysis Plan for a Randomised Controlled Trial of the Effectiveness of Vaporised Nicotine Products for Tobacco Smoking Cessation amongst NSW Opiate Agonist Treatment ClientsSemantic proximity
Pharmacological Smoking Cessation Interventions in People with Cannabis, Opioid, or Stimulant Use Disorders: A Systematic ReviewSemantic proximity
HARMONY (HARM reduction for Opiates, Nicotine and You) Trial: Protocol of a Randomised Controlled Trial of the Effectiveness of Vaporised Nicotine Products for Tobacco Smoking Cessation amongst NSW Opiate Agonist Treatment ClientsSemantic proximity
Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.Semantic proximity
Smoking in patients with schizophrenia: Prevalence rate and connections with cognitive functions, psychiatric symptoms, and clinical and demographic characteristicsSemantic proximity
Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx SmokersSemantic proximity
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: a systematic review and meta-analysisSemantic proximity
What's new in nicotine & tobacco research?Semantic proximity
Select a neighboring publication to make it the new centre.